Wave Life Sciences Ltd. (NASDAQ: WVE) kicked off on Tuesday, down -1.85% from the previous trading day, before settling in for the closing price of $15.11. Over the past 52 weeks, WVE has traded in a range of $3.50-$15.92.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 610.91%. While this was happening, its average annual earnings per share was recorded -87.66%. With a float of $120.08 million, this company’s outstanding shares have now reached $154.93 million.
Considering the fact that the conglomerate employs 268 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 92.04%, operating margin of -75.74%, and the pretax margin is -67.11%.
Wave Life Sciences Ltd. (WVE) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Wave Life Sciences Ltd. is 22.49%, while institutional ownership is 65.24%. The most recent insider transaction that took place on Oct 16 ’24, was worth 2,855,051. In this transaction an insider of this company sold 208,836 shares at a rate of $13.67, taking the stock ownership to the 0 shares. Before that another transaction happened on Oct 16 ’24, when Company’s President and CEO sold 90,474 for $15.00, making the entire transaction worth $1,357,110. This insider now owns 268,585 shares in total.
Wave Life Sciences Ltd. (WVE) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -87.66% per share during the next fiscal year.
Wave Life Sciences Ltd. (NASDAQ: WVE) Trading Performance Indicators
Take a look at Wave Life Sciences Ltd.’s (WVE) current performance indicators. Last quarter, stock had a quick ratio of 0.99. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 20.79.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.58, a number that is poised to hit -0.28 in the next quarter and is forecasted to reach -0.98 in one year’s time.
Technical Analysis of Wave Life Sciences Ltd. (WVE)
Compared to the last year’s volume of 1.1 million, its volume of 5.4 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 89.47%. Additionally, its Average True Range was 1.00.
During the past 100 days, Wave Life Sciences Ltd.’s (WVE) raw stochastic average was set at 90.66%, which indicates a significant increase from 86.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 231.12% in the past 14 days, which was higher than the 130.10% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.47, while its 200-day Moving Average is $5.97. Nevertheless, the first resistance level for the watch stands at $15.15 in the near term. At $15.47, the stock is likely to face the second major resistance level. The third major resistance level sits at $15.73. If the price goes on to break the first support level at $14.57, it is likely to go to the next support level at $14.32. Should the price break the second support level, the third support level stands at $14.00.
Wave Life Sciences Ltd. (NASDAQ: WVE) Key Stats
The company with the Market Capitalisation of 2.30 billion has total of 122,475K Shares Outstanding. Its annual sales at the moment are 113,310 K in contrast with the sum of -57,510 K annual income. Company’s last quarter sales were recorded 19,690 K and last quarter income was -32,920 K.
